This webinar will describe the role that the reference material manufacturer plays by providing the tools needed to respond to the current opioid epidemic.
Whether by rapidly providing authentic reference standards of novel emerging drugs of abuse or the analytical instrumentation necessary to identify them in casework, private forensic industry partners play a critical role in the response to the opioid crisis. The speed at which novel psychoactive substances are encountered in forensic casework has significantly increased over the past few years. To aid the forensic community in the identification of new substances in seized bulk materials and counterfeit pills or metabolites in bodily fluids, reference material manufacturers such as Cayman Chemical have had quite the challenge to synthesize and qualify our materials in the most expedient manner.
Rapid communication and collaboration with industry is needed to adequately respond to the current crisis. This webinar will describe the role that the reference material manufacturer plays by providing the tools needed to respond to the current opioid epidemic. Recent examples of how this has been successful will be presented as well as tips for strengthening this connection.
A certificate of completion is available for all who register and attend this webinar.
- Donna M. Iula, Ph.D.
- Roxanne E. Franckowski
Funding for this Forensic Technology Center of Excellence webinar has been provided by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice.
The opinions, findings, and conclusions or recommendations expressed in this webinar are those of the presenter(s) and do not necessarily reflect those of the U.S. Department of Justice.